Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Gut

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%

Progression‐free survival (PSF) · people with advanced gastric cancer

Irinotecan leads to lower progression‐free survival ‐ Other comparisons compared with non‐irinotecan‐containing regimens (high certainty).

1 finding from 1 review

Chemotherapy for advanced gastric cancer 2017 · Cochrane Headline outcomes only
HR 0.74 [0.66, 0.84]
2 studies · 809 participants
High